| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.11 | 0.4 |